Vascular Screening Devices Market Report
First published: 08 October 2024 | Last updated: 28 May 2026 | Report Code: vascular-screening-devices
Vascular Screening Devices Market — USD 5.8 billion in 2023, Growing to USD 10.75B by 2033 at 6.2% CAGR
This report provides an in-depth analysis of the vascular screening devices market from 2023 to 2033, including market size, growth trends, regional analysis, and competitive landscape, aiming to offer insights for stakeholders to devise strategic approaches.
Key Takeaways
- Global market value rises from $5.80 Billion (2023) to $10.75 Billion (2033) with a 6.2% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America leads regional value, growing from $2.2 Billion to $4.07 Billion by 2033.
- Europe and Asia Pacific each show notable expansion: Europe from $1.51 Billion to $2.79 Billion; Asia Pacific from $1.14 Billion to $2.12 Billion.
- Market adoption driven by hospitals, clinics, and diagnostic centres using non-invasive and invasive technologies.
- Leading companies include GE Healthcare, Philips Healthcare, Siemens Healthineers, Toshiba Medical Systems, and Medtronic.
Vascular Screening Devices Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The vascular screening devices market is projected to expand substantially between 2023 and 2033, moving from $5.80 Billion to $10.75 Billion at a 6.2% CAGR. Growth is supported by rising chronic disease prevalence, demand for early detection, and investments in imaging capabilities. Hospitals, clinics, and diagnostic centres represent primary end-users adopting both non-invasive and invasive device classes, including ultrasound, CT, and MRI systems. Technology improvements, increasing portability, and focus on preventive care are key trends. Established suppliers such as GE Healthcare, Philips Healthcare, Siemens Healthineers, Toshiba Medical Systems, and Medtronic play central roles through product development and market reach. Regional dynamics vary: North America holds the largest market value, while Europe, Asia Pacific, Latin America, and Middle East & Africa contribute through expanding healthcare infrastructure and diagnostic services. Regulatory requirements and integration challenges remain considerations for providers and purchasers. The report synthesizes primary interviews, company disclosures, and triangulated data to map opportunities and risks for stakeholders across the value chain.
Key Growth Drivers
- Increasing prevalence of vascular and chronic diseases raising screening demand in clinical settings.
- Advances in imaging and device portability improving access to point-of-care diagnostics.
- Greater emphasis on preventive healthcare and early detection by hospitals and diagnostic centres.
- Investment by leading vendors in product innovation and expanded service offerings.
- Rising availability of non-invasive screening technologies enhancing patient acceptance and throughput.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.80 Billion |
| CAGR (2023-2033) | 6.2% |
| 2033 Market Size | $10.75 Billion |
| Top Companies | GE Healthcare, Philips Healthcare, Siemens Healthineers, Toshiba Medical Systems, Medtronic |
| Published Date | 08 October 2024 |
| Last Modified Date | 28 May 2026 |
Vascular Screening Devices Market Overview
Customize Vascular Screening Devices Market Report market research report
- ✔ Get in-depth analysis of Vascular Screening Devices market size, growth, and forecasts.
- ✔ Understand Vascular Screening Devices's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Vascular Screening Devices
What is the Market Size & CAGR of Vascular Screening Devices Market Report market in 2023?
Vascular Screening Devices Industry Analysis
Vascular Screening Devices Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Vascular Screening Devices Market Report Market Analysis Report by Region
Europe Vascular Screening Devices Market Report:
Europe grows from $1.51 Billion in 2023 to $2.79 Billion in 2033. Expansion is supported by healthcare investments, emphasis on early disease detection, and uptake of imaging technologies in diagnostic centres and hospitals.Asia Pacific Vascular Screening Devices Market Report:
Asia Pacific grows from $1.14 Billion in 2023 to $2.12 Billion in 2033. Growth factors include expanding diagnostic capacity, increasing prevalence of chronic conditions, and greater availability of non-invasive screening devices.North America Vascular Screening Devices Market Report:
North America is largest regional market, rising from $2.2 Billion in 2023 to $4.07 Billion in 2033. Regional drivers include advanced healthcare infrastructure, high diagnostic service uptake in hospitals and clinics, and vendor presence supporting product adoption.South America Vascular Screening Devices Market Report:
Latin America grows from $0.4 Billion in 2023 to $0.74 Billion in 2033. Market gains are linked to improving healthcare infrastructure, growing diagnostic services, and rising awareness of vascular disease screening.Middle East & Africa Vascular Screening Devices Market Report:
Middle East and Africa grows from $0.55 Billion in 2023 to $1.03 Billion in 2033. Drivers include gradual healthcare system development, expansion of diagnostic centres, and investment in imaging equipment.Tell us your focus area and get a customized research report.
Research Methodology
Vascular Screening Devices Market Analysis By Device Type
The market for vascular screening devices by device type is heavily influenced by the performance of ultrasound devices, which dominate with a projected market size of $7.17 billion by 2033, doubling from $3.87 billion in 2023. Other significant devices include CT scanners and MRI machines, with market sizes of $2.54 billion and $1.04 billion, respectively, by 2033.
Vascular Screening Devices Market Analysis By Technology
The vascular screening devices market by technology highlights the dominance of non-invasive technologies, which are expected to grow from $4.90 billion in 2023 to $9.08 billion in 2033. Invasive technologies also play a role but remain smaller in size, growing from $0.90 billion to $1.67 billion over the same period, focusing on specific diagnostic applications.
Vascular Screening Devices Market Analysis By Application
In terms of application, the diagnosis segment remains the largest, with expected growth from $3.87 billion in 2023 to $7.17 billion by 2033. Monitoring applications follow closely behind, growing significantly from $1.37 billion to $2.54 billion during the forecast period, highlighting the trend towards continuous health assessment.
Vascular Screening Devices Market Analysis By End User
Hospitals are the key end-users, with a market size projected to increase from $3.87 billion in 2023 to $7.17 billion by 2033. Clinics and diagnostic centers are also critical, with growth indicators showcasing increasing investments in vascular diagnostic equipment to meet rising patient care demands.
Vascular Screening Devices Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Vascular Screening Devices Industry
GE Healthcare:
GE Healthcare offers a comprehensive range of imaging and diagnostics technologies, leading the market with innovative vascular screening solutions to enhance patient care.Philips Healthcare:
Philips Healthcare specializes in advanced imaging and ultrasound systems, significantly contributing to the vascular screening devices market with a focus on patient-centered solutions.Siemens Healthineers:
Siemens Healthineers is renowned for its cutting-edge imaging technologies and diagnostic solutions, driving advancements in vascular health through innovative devices and diagnostic platforms.Toshiba Medical Systems:
Toshiba Medical is known for its high-quality imaging systems and vascular devices, contributing to enhanced diagnostic capabilities across various medical settings.Medtronic :
Medtronic is a global leader in medical technology, providing vascular products that improve patient outcomes through innovative device solutions.We're grateful to work with incredible clients.
FAQs
What is the market size of the Vascular Screening Devices Market Report in 2023?
The market size in 2023 is $5.80 Billion, as stated for the base year in the report data provided.
How big will the market be in 2033?
By 2033 the market is projected to reach $10.75 Billion, according to the given forecast figures.
What is CAGR for the forecast period?
The provided compound annual growth rate for 2023 to 2033 is 6.2%.
Is there a single fastest Growing region in the Vascular Screening Devices Market Report market?
No single fastest-growing region is stated for the Vascular Screening Devices Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as key players?
Top companies named include GE Healthcare, Philips Healthcare, Siemens Healthineers, Toshiba Medical Systems, and Medtronic.
What end Users are covered in the segmentation?
End-user sub segments specified are Hospitals, Clinics, and Diagnostic Centres as primary purchasers and users of screening devices.
What device types does the report include?
Device-type sub segments listed are Ultrasound Devices, CT Scanners, and MRI Machines in the provided segmentation details.
How was the research compiled for this report?
Research combined primary interviews with industry experts and secondary sources such as company reports, followed by data triangulation and internal validation.
What technologies are covered in the analysis?
The technology sub segments specified are Non-Invasive Technology and Invasive Technology across screening solutions.
Why is preventive care important for market growth?
Preventive care drives demand as healthcare systems prioritize early detection, increasing adoption of efficient vascular screening tools in clinical workflows.